Fmoc-Phe-Gly-OCH3
1316293-48-7
|
H-Phe-Gly-NH2 · HCl
38678-61-4
|
Pyr-Phe-Gly-NH2
203396-25-2
|
Boc-Phe-Gly-NH2
42726-70-5
|
Pro-Phe-Gly-NH2
114390-34-0
|
Z-Phe-Gly-NH2
17187-05-2
|
N-Ac-Phe-Gly-NH2
29701-43-7
|
H-Tyr-D-Ala-Phe-Gly-NH2 (trifluoroacetate)
89661-94-9
|
Fmoc-L-Phe-NH2
112667-29-5
|
5(4H)-Isoxazolone, 4-(1-aminoethylidene)-3-ethyl-
916612-52-7
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
2-bromo-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1,3,8(16),9,11(15)-pentaene-5,7,12,14-tetrone
1817659-62-3
|
N'-hydroxy-1-methyl-1H-pyrazole-3-carboximidamide
1345124-49-3
|
Methyl(R)-2-amino-2-(2-chloro-5-fluorophenyl)acetatehcl
1703893-14-4
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
